Search research articles
Contact Us
Filters
Showing results (271-280 of 290) with videos related to
Page
of 29
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 30, 2009
Selective removal of stratum corneum by microdermabrasion to increase skin permeability
Harvinder S Gill, Samantha N Andrews, Senthilkumar K Sakthivel, et al.
Vaccine
|
March 17, 2015
An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine
Bruce Y Lee, Sarah M Bartsch, Mercy Mvundura, et al.
The Journal of Infectious Diseases
|
April 28, 2018
A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques
Jessica C Joyce, Timothy D Carroll, Marcus L Collins, et al.
Plos One
|
March 19, 2015
Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles
Rhonda C Kines, Vladimir Zarnitsyn, Teresa R Johnson, et al.
Journal of the Pediatric Infectious Diseases Society
|
February 2, 2026
Safety, Reactogenicity, and Acceptability of a Placebo Dissolving Microneedle Patch in Children
Carol M Kao, Christina A Rostad, Peggy Kettle, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 3, 2018
Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza
Elizabeth Q Littauer, Lisa K Mills, Nicole Brock, et al.
Human Vaccines & Immunotherapeutics
|
August 8, 2020
Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies
Jacob T Beaver, Lisa K Mills, Dominika Swieboda, et al.
Trials
|
September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]
Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
Journal of Functional Biomaterials
|
January 20, 2023
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge
Andrey Romanyuk, Ruixue Wang, Alexander Marin, et al.
Scientific Reports
|
February 23, 2012
Visualization of plasmid delivery to keratinocytes in mouse and human epidermis
Emilio González-González, Yeu-Chun Kim, Tycho J Speaker, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 290) with videos related to
Sort By:
Page
of 29
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 30, 2009
Selective removal of stratum corneum by microdermabrasion to increase skin permeability
Harvinder S Gill, Samantha N Andrews, Senthilkumar K Sakthivel, et al.
Vaccine
|
March 17, 2015
An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine
Bruce Y Lee, Sarah M Bartsch, Mercy Mvundura, et al.
The Journal of Infectious Diseases
|
April 28, 2018
A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques
Jessica C Joyce, Timothy D Carroll, Marcus L Collins, et al.
Plos One
|
March 19, 2015
Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles
Rhonda C Kines, Vladimir Zarnitsyn, Teresa R Johnson, et al.
Journal of the Pediatric Infectious Diseases Society
|
February 2, 2026
Safety, Reactogenicity, and Acceptability of a Placebo Dissolving Microneedle Patch in Children
Carol M Kao, Christina A Rostad, Peggy Kettle, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 3, 2018
Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza
Elizabeth Q Littauer, Lisa K Mills, Nicole Brock, et al.
Human Vaccines & Immunotherapeutics
|
August 8, 2020
Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies
Jacob T Beaver, Lisa K Mills, Dominika Swieboda, et al.
Trials
|
September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]
Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
Journal of Functional Biomaterials
|
January 20, 2023
Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge
Andrey Romanyuk, Ruixue Wang, Alexander Marin, et al.
Scientific Reports
|
February 23, 2012
Visualization of plasmid delivery to keratinocytes in mouse and human epidermis
Emilio González-González, Yeu-Chun Kim, Tycho J Speaker, et al.
Page
of 29